Search
for
Sort by
Research 31–60 of 1000+
- Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation
- The PDGF/PDGFR pathway as a drug target
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- The pathophysiology of delayed ejaculation
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Effect of ethanol extract of Zapoteca portoricensis stem on liver, kidney and prostatic biomarkers of testosterone-induced benign prostate hyperplasia (BPH) in male albino rats
- Getting to grips with hair loss
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Liposuction and Tumescent Surgery
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Abstract 2205: KRTAP 2-3 is a novel potential biomarker of cells in the polyaneuploid cancer cell (PACC) state to predict cancer recurrence
- 1424 METHYLATION AND DECREASED EXPRESSION OF 5-ALPHA REDUCTASE 2 IN HUMAN PROSATE SAMPLES: IMPLICATIONS FOR RESISTANCE TO THERAPY FOR BPH
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Editorial Comment